Vistry Group, a leading UK homebuilder, recorded a 9% decline in house sales during 2025, reflecting broader market challenges tied to economic uncertainty and shifting consumer confidence. The drop underscores growing headwinds in the residential construction sector.
- Vistry Group delivered 10,745 homes in 2025, a 9% drop from 11,808 in 2024.
- Revenue from home sales decreased by £187 million to £1.9 billion in 2025.
- Adjusted operating profit fell 7% to £362 million.
- Over 65% of 2025 sales involved existing homeowners or investors.
- Average monthly completions declined by 13% in the first half of 2025 compared to 2024.
Vistry Group reported a 9% year-on-year decrease in completed home sales across its UK operations in 2025, with total units delivered falling to 10,745 from 11,808 in the previous year. This contraction occurred despite continued activity in key regions including the Midlands and South East, where the company maintained a steady pipeline of new developments. The decline is attributed to prolonged fiscal ambiguity, rising mortgage rates, and constrained household budgets following the 2024 budget announcement that deferred several planned housing incentives. Consumer hesitation was particularly evident in the first half of 2025, when average monthly completions dropped by nearly 13% compared to the same period in 2024. Financial data shows Vistry's revenue from homes fell by £187 million in 2025, totaling £1.9 billion, while adjusted operating profit declined by 7% to £362 million. The company noted that affordability constraints were most pronounced among first-time buyers, with over 65% of transactions in 2025 involving existing homeowners or investors. Market analysts observe that the slowdown has prompted a reassessment of growth targets across the sector. Competitors such as Redrow and Persimmon have also reported similar trends, with some scaling back on new starts. Investors reacted cautiously, with Vistry Group's share price declining 4.2% in early trading following the release of the results.